Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Nov;109(11):1091–1094. doi: 10.1289/ehp.011091091

Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A.

J Ashby 1
PMCID: PMC1240467  PMID: 11712991

Abstract

The gravimetric uterotrophic assay is currently the most well-established, short-term rodent estrogenicity assay. Increasing attention is being paid to the extent to which use of morphometric or molecular changes in the uterus could act as surrogates for the gravimetric end point of the assay, thereby perhaps increasing the sensitivity of the assay. In this paper I discuss the available data, paying particular attention to studies on bisphenol A (BPA) because it offers the largest database for consideration. I conclude that the case has yet to be made for augmenting the gravimetric end point of the uterotrophic assay. To resolve this important question, it will be necessary to conduct detailed dose-response studies where the no-observed-effect level (NOEL) for the proposed surrogate end points are compared with the NOEL for the gravimetric end point. Currently, few such studies exist, and among those that do no clear message emerges. The general trend to increasing use of molecular assays in toxicology (multigene microarrays and real-time polymerase chain reaction) emphasizes the need for clear criteria for comparing the performance of individual markers of toxicity.

Full Text

The Full Text of this article is available as a PDF (480.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashby J. Getting the problem of endocrine disruption into focus: the need for a pause for thought. APMIS. 2000 Dec;108(12):805–813. doi: 10.1111/j.1600-0463.2000.tb00002.x. [DOI] [PubMed] [Google Scholar]
  2. Ashby J., Odum J., Foster J. R. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays. Regul Toxicol Pharmacol. 1997 Jun;25(3):226–231. doi: 10.1006/rtph.1997.1108. [DOI] [PubMed] [Google Scholar]
  3. Ashby J., Odum J., Paton D., Lefevre P. A., Beresford N., Sumpter J. P. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicol Lett. 2000 Jun 5;115(3):231–238. doi: 10.1016/s0378-4274(00)00198-3. [DOI] [PubMed] [Google Scholar]
  4. Ashby J., Tinwell H., Odum J., Kimber I., Brooks A. N., Pate I., Boyle C. C. Diet and the aetiology of temporal advances in human and rodent sexual development. J Appl Toxicol. 2000 Sep-Oct;20(5):343–347. doi: 10.1002/1099-1263(200009/10)20:5<343::AID-JAT719>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  5. Ashby J., Tinwell H., Pennie W., Brooks A. N., Lefevre P. A., Beresford N., Sumpter J. P. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol. 1999 Jan-Feb;19(1):39–45. doi: 10.1002/(sici)1099-1263(199901/02)19:1<39::aid-jat534>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  6. Ashby J., Tinwell H. Uterotrophic activity of bisphenol A in the immature rat. Environ Health Perspect. 1998 Nov;106(11):719–720. doi: 10.1289/ehp.98106719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Black L. J., Sato M., Rowley E. R., Magee D. E., Bekele A., Williams D. C., Cullinan G. J., Bendele R., Kauffman R. F., Bensch W. R. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 1994 Jan;93(1):63–69. doi: 10.1172/JCI116985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coldham N. G., Dave M., Sivapathasundaram S., McDonnell D. P., Connor C., Sauer M. J. Evaluation of a recombinant yeast cell estrogen screening assay. Environ Health Perspect. 1997 Jul;105(7):734–742. doi: 10.1289/ehp.97105734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Das S. K., Taylor J. A., Korach K. S., Paria B. C., Dey S. K., Lubahn D. B. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12786–12791. doi: 10.1073/pnas.94.24.12786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freyberger A., Hartmann E., Hildebrand H., Krötlinger F. Differential response of immature rat uterine tissue to ethinylestradiol and the red wine constituent resveratrol. Arch Toxicol. 2001 Jan;74(11):709–715. doi: 10.1007/s002040000186. [DOI] [PubMed] [Google Scholar]
  11. Ghosh D., Taylor J. A., Green J. A., Lubahn D. B. Methoxychlor stimulates estrogen-responsive messenger ribonucleic acids in mouse uterus through a non-estrogen receptor (non-ER) alpha and non-ER beta mechanism. Endocrinology. 1999 Aug;140(8):3526–3533. doi: 10.1210/endo.140.8.6877. [DOI] [PubMed] [Google Scholar]
  12. Gould J. C., Leonard L. S., Maness S. C., Wagner B. L., Conner K., Zacharewski T., Safe S., McDonnell D. P., Gaido K. W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol. 1998 Jul 25;142(1-2):203–214. doi: 10.1016/s0303-7207(98)00084-7. [DOI] [PubMed] [Google Scholar]
  13. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Ashby J., Owens W., Organisation for Economic Co-operation and Development The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ Health Perspect. 2001 Aug;109(8):785–794. doi: 10.1289/ehp.01109785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Korach K. S., Levy L. A., Sarver P. J. Estrogen receptor stereochemistry: receptor binding and hormonal responses. J Steroid Biochem. 1987;27(1-3):281–290. doi: 10.1016/0022-4731(87)90319-0. [DOI] [PubMed] [Google Scholar]
  15. Laws S. C., Carey S. A., Ferrell J. M., Bodman G. J., Cooper R. L. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci. 2000 Mar;54(1):154–167. doi: 10.1093/toxsci/54.1.154. [DOI] [PubMed] [Google Scholar]
  16. Long X., Steinmetz R., Ben-Jonathan N., Caperell-Grant A., Young P. C., Nephew K. P., Bigsby R. M. Strain differences in vaginal responses to the xenoestrogen bisphenol A. Environ Health Perspect. 2000 Mar;108(3):243–247. doi: 10.1289/ehp.00108243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Markey C. M., Michaelson C. L., Veson E. C., Sonnenschein C., Soto A. M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect. 2001 Jan;109(1):55–60. doi: 10.1289/ehp.0110955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Matthews J. B., Twomey K., Zacharewski T. R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol. 2001 Feb;14(2):149–157. doi: 10.1021/tx0001833. [DOI] [PubMed] [Google Scholar]
  19. Mehmood Z., Smith A. G., Tucker M. J., Chuzel F., Carmichael N. G. The development of methods for assessing the in vivo oestrogen-like effects of xenobiotics in CD-1 mice. Food Chem Toxicol. 2000 Jun;38(6):493–501. doi: 10.1016/s0278-6915(00)00022-3. [DOI] [PubMed] [Google Scholar]
  20. Newbold R. R., Jefferson W. N., Padilla-Banks E., Walker V. R., Pena D. S., Developmental Endocrinology Studies Group Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol. 2001 May-Jun;15(3):245–252. doi: 10.1016/s0890-6238(01)00130-7. [DOI] [PubMed] [Google Scholar]
  21. Papaconstantinou A. D., Umbreit T. H., Fisher B. R., Goering P. L., Lappas N. T., Brown K. M. Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicol Sci. 2000 Aug;56(2):332–339. doi: 10.1093/toxsci/56.2.332. [DOI] [PubMed] [Google Scholar]
  22. Steinmetz R., Mitchner N. A., Grant A., Allen D. L., Bigsby R. M., Ben-Jonathan N. The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract. Endocrinology. 1998 Jun;139(6):2741–2747. doi: 10.1210/endo.139.6.6027. [DOI] [PubMed] [Google Scholar]
  23. Tinwell H., Joiner R., Pate I., Soames A., Foster J., Ashby J. Uterotrophic activity of bisphenol A in the immature mouse. Regul Toxicol Pharmacol. 2000 Aug;32(1):118–126. doi: 10.1006/rtph.2000.1412. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES